ChemoSen Cancer Research Results

ChemoSen, chemo-sensitization: Click to Expand ⟱
Source:
Type:
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”.

Possible Chemo-Sensitizers:
-Curcumin
-Resveratrol
-EGCG
-Quercetin
-Genistein
-Berberine
-Piperine: alkaloid from black pepper
-Ginsenosides: active components of ginseng
-Silymarin
-Allicin
-Lycopene
-Ellagic acid
-Caffeic acid phenethyl ester
-flavopiridol
-oleandrin
-Ursolic acid
-butein
-Betulinic acid



Scientific Papers found: Click to Expand⟱
8591- FS,  doxoR,  carbop,    Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, SkBr3
ChemoSen?, Synergy↑, chemoP↑,
8592- FS,  Tras,    Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474)
- in-vitro, BC, BT20
ChemoSen?, HER2/EBBR2↓, Akt↓, MAPK↓, TumCP↓, Apoptosis↑,
9173- ITCs,  SFN,    Dietary isothiocyanates and anticancer agents: exploring synergism for improved cancer management
- Review, Var, NA
Synergy↑, AntiCan↑, chemoP↑, ChemoSen?, toxicity↓, ROS↑, NRF2↑, NF-kB↓, CYP1A1↓, CYP1A2↓, CYP1B1↓, TumCCA↑, PI3K↓, Akt↓, mTOR↓, PTEN↑, BAX↑, ChemoSen↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Dose↝, Synergy↑,
8557- Matr,    Effects of matrine in combination with cisplatin on liver cancer
- in-vivo, Liver, HepG2
ChemoSen?, TumW↓, TumVol↓, survivin↓, XIAP↓, Casp3↑, Casp7↑, Casp9↑,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,
8465- TQ,  docx,    Thymoquinone Potentiates Docetaxel-Induced Antitumor Activity with the Involvement of ROS and PI3K/AKT Pathway Modulation in Triple-Negative Breast Cancer Cells
- in-vitro, BC, NA
ChemoSen?, ROS↑, eff↓, Bcl-2↓, PI3K↓, AKT1↓, BAX↑, Casp9↑, PTEN↑,

Showing Research Papers: 1 to 6 of 6

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

NRF2↑, 1,   ROS↑, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 1,   BAX↑, 2,   Bcl-2↓, 1,   Casp3↑, 2,   Casp7↑, 1,   Casp9↑, 2,   Cyt‑c↑, 1,   survivin↓, 1,   XIAP↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   AKT1↓, 1,   BRAF↓, 1,   DYRK1B↓, 1,   HER2/EBBR2↓, 1,   MAPK↓, 1,   MEK↓, 1,   mTOR↓, 1,   PI3K↓, 2,   PTEN↑, 2,  

DNA Damage & Repair(tgid=10) ⓘ

cl‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

mitA↑, 1,   TubPol↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Gli1↓, 1,   HH↓, 1,   PTCH2↓, 1,   Shh↓, 1,   TumCG↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

MMPs↓, 1,   TumMeta?, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   VCAM-1↓, 1,   VEGF↓, 1,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

NF-kB↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 1,   ChemoSen?, 6,   ChemoSen↑, 1,   CYP1A1↓, 1,   CYP1A2↓, 1,   CYP1B1↓, 1,   Dose↝, 2,   eff↓, 1,   MDR1↓, 1,   RadioS?, 1,   Synergy↑, 9,  

Clinical Biomarkers(tgid=22) ⓘ

BRAF↓, 1,   HER2/EBBR2↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 1,   chemoP↑, 2,   OS↑, 1,   QoL↑, 1,   toxicity↓, 1,   TumVol↓, 2,   TumW↓, 1,  
Total Targets: 61

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: ChemoSen, chemo-sensitization
2 Flaxseed/Linseed
1 doxorubicin
1 carboplatin
1 Trastuzumab
1 Isothiocyanates
1 Sulforaphane (mainly Broccoli)
1 Matrine
1 mebendazole
1 Thymoquinone
1 Docetaxel
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:1106  State#:%  Dir#:0
wNotes=0 sortOrder:rid,rpid

 

Home Page